E
Kintara Therapeutics, Inc.
KTRA
NASDAQ
E
Sell
3/14/2023Downgrade
Kintara Therapeutics, Inc. (KTRA) was downgraded to E+ from D on 3/14/2023 due to a decline in the solvency index.
Kintara Therapeutics, Inc. (KTRA) was downgraded to E+ from D on 3/14/2023 due to a decline in the solvency index.
D
Sell
2/9/2023Upgraded
Kintara Therapeutics, Inc. (KTRA) was upgraded to D from E+ on 2/9/2023 due to an increase in the total return index and volatility index.
Kintara Therapeutics, Inc. (KTRA) was upgraded to D from E+ on 2/9/2023 due to an increase in the total return index and volatility index.
E
Sell
2/8/2023Downgrade
Kintara Therapeutics, Inc. (KTRA) was downgraded to E+ from D on 02/08/2023.
Kintara Therapeutics, Inc. (KTRA) was downgraded to E+ from D on 02/08/2023.
D
Sell
11/16/2022Upgraded
Kintara Therapeutics, Inc. (KTRA) was upgraded to D from D- on 11/16/2022 due to an increase in the volatility index, growth index and total return index. Earnings per share increased from -$4.325 to -$3.3877, and EBIT increased 14.88% from -$5.46M to -$4.65M.
Kintara Therapeutics, Inc. (KTRA) was upgraded to D from D- on 11/16/2022 due to an increase in the volatility index, growth index and total return index. Earnings per share increased from -$4.325 to -$3.3877, and EBIT increased 14.88% from -$5.46M to -$4.65M.
D
Sell
11/7/2022Downgrade
Kintara Therapeutics, Inc. (KTRA) was downgraded to D- from D on 11/7/2022 due to a decline in the volatility index and total return index.
Kintara Therapeutics, Inc. (KTRA) was downgraded to D- from D on 11/7/2022 due to a decline in the volatility index and total return index.
D
Sell
9/20/2022Upgraded
Kintara Therapeutics, Inc. (KTRA) was upgraded to D from D- on 9/20/2022 due to an increase in the volatility index and total return index.
Kintara Therapeutics, Inc. (KTRA) was upgraded to D from D- on 9/20/2022 due to an increase in the volatility index and total return index.
D
Sell
9/2/2022Downgrade
Kintara Therapeutics, Inc. (KTRA) was downgraded to D- from D on 9/2/2022 due to a decline in the volatility index.
Kintara Therapeutics, Inc. (KTRA) was downgraded to D- from D on 9/2/2022 due to a decline in the volatility index.
D
Sell
8/15/2022Upgraded
Kintara Therapeutics, Inc. (KTRA) was upgraded to D from D- on 8/15/2022 due to an increase in the total return index and volatility index.
Kintara Therapeutics, Inc. (KTRA) was upgraded to D from D- on 8/15/2022 due to an increase in the total return index and volatility index.
D
Sell
5/31/2022Downgrade
Kintara Therapeutics, Inc. (KTRA) was downgraded to D- from D on 5/31/2022 due to a decline in the total return index.
Kintara Therapeutics, Inc. (KTRA) was downgraded to D- from D on 5/31/2022 due to a decline in the total return index.
D
Sell
5/16/2022Upgraded
Kintara Therapeutics, Inc. (KTRA) was upgraded to D from E+ on 5/16/2022 due to an increase in the valuation index.
Kintara Therapeutics, Inc. (KTRA) was upgraded to D from E+ on 5/16/2022 due to an increase in the valuation index.
E
Sell
5/1/2022Downgrade
Kintara Therapeutics, Inc. (KTRA) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index and volatility index.
Kintara Therapeutics, Inc. (KTRA) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index and volatility index.
D
Sell
4/21/2022Upgraded
Kintara Therapeutics, Inc. (KTRA) was upgraded to D from E+ on 04/21/2022.
Kintara Therapeutics, Inc. (KTRA) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
Kintara Therapeutics, Inc. (KTRA) was downgraded to E+ from D on 4/20/2022 due to a large decline in the total return index, valuation index and volatility index.
Kintara Therapeutics, Inc. (KTRA) was downgraded to E+ from D on 4/20/2022 due to a large decline in the total return index, valuation index and volatility index.
D
Sell
11/3/2021Upgraded
Kintara Therapeutics, Inc. (KTRA) was upgraded to D from D- on 11/3/2021 due to an increase in the valuation index.
Kintara Therapeutics, Inc. (KTRA) was upgraded to D from D- on 11/3/2021 due to an increase in the valuation index.
D
Sell
10/14/2021Downgrade
Kintara Therapeutics, Inc. (KTRA) was downgraded to D- from D on 10/14/2021 due to a large decline in the growth index and valuation index. EBIT declined 1.39% from -$6.61M to -$6.7M, and operating cash flow declined 1.27% from -$4.63M to -$4.69M.
Kintara Therapeutics, Inc. (KTRA) was downgraded to D- from D on 10/14/2021 due to a large decline in the growth index and valuation index. EBIT declined 1.39% from -$6.61M to -$6.7M, and operating cash flow declined 1.27% from -$4.63M to -$4.69M.
D
Sell
8/28/2020None
Kintara Therapeutics, Inc. (KTRA) was downgraded to D from U on 08/28/2020.
Kintara Therapeutics, Inc. (KTRA) was downgraded to D from U on 08/28/2020.
